Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 15/20 | 0.36 |
| ▸ | TDP2 | O95551 | 1/20 | 0.31 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.31 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.31 |
| ▸ | ESR1 | P03372 | 1/20 | 0.30 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1921164 | 0.91 | TDP2 (0.35) | TDP2 | |
| SCHEMBL1921347 | 0.83 | PDK2 (0.34) | PDK2GABRA1GABRB2 | |
| SCHEMBL28199301 | 0.82 | PDK2 (0.40) | PDK2TDP2ESR1ESR2 | |
| SCHEMBL1921507 | 0.79 | PDK2 (0.50) | PDK2 | |
| SCHEMBL1920765 | 0.79 | PDK2 (0.50) | PDK2 | |
| Hydrochloric Acid SCHEMBL27969207 | 0.79 | PDK2 (0.50) | PDK2ESR1ESR2 | |
| SCHEMBL23936096 | 0.76 | PDK2 (0.35) | PDK2TDP2ESR1ESR2 | |
| SCHEMBL431200 | 0.76 | HTR2A (0.38) | PDK2TDP2ESR1ESR2 | |
| SCHEMBL29508649 | 0.76 | HTR2A (0.38) | PDK2TDP2ESR1ESR2 | |
| SCHEMBL13523410 | 0.75 | KDM4E (0.41) | PDK2TDP2ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2327739-B1 | Novel triarylamine polymer, process for its production and its use | TOSOH CORP (JP) | 2014-05-07 | — | — | EP | disclosed |
| EP-1528074-B1 | NOVEL TRIARYLAMINE POLYMER, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | TOSOH CORP (JP) | 2014-03-26 | — | — | EP | disclosed |
| CN-101410356-B | Novel compound and organic light emitting device using the same | CANON KK | 2013-08-07 | — | — | CN | disclosed |
| US-8384286-B2 | Compound and organic light emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2013-02-26 | — | — | US | disclosed |
| CN-102629663-A | Novel compound and organic light emitting device using the compound | CANON KK | 2012-08-08 | — | — | CN | disclosed |
| US-20120043535-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2012-02-23 | — | — | US | disclosed |
| US-8072136-B2 | Compound and organic light emitting device using the compound | CANON KABUSHIKI KAISHA (JP) | 2011-12-06 | — | — | US | disclosed |
| EP-2327739-A1 | Novel triarylamine polymer, process for its production and its use | TOSOH CORPORATION (JP) | 2011-06-01 | — | — | EP | disclosed |
| EP-2004580-B1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE COMPOUND | CANON KK (JP) | 2011-05-25 | — | — | EP | disclosed |
| US-20100176716-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2010-07-15 | — | — | US | disclosed |
| US-7608680-B2 | Triarylamine polymer, process for producing the same, and use thereof | TOSOH CORPORATION (JP) | 2009-10-27 | — | — | US | disclosed |
| EP-2004580-A4 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE COMPOUND | CANON KK (JP) | 2009-07-15 | — | — | EP | disclosed |
| CN-101410356-A | Novel compound and organic light emitting device using the same | CANON KK (JP) | 2009-04-15 | — | — | CN | disclosed |
| EP-2004580-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE COMPOUND | Canon Kabushiki Kaisha (JP) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007114038-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE COMPOUND | CANON KABUSHIKI KAISHA (JP) | 2007-10-11 | — | — | WO | disclosed |
| US-20060241278-A1 | Novel triarylamine polymer, process for producing the same, and use thereof | TOSOH CORPORATION (JP) | 2006-10-26 | — | — | US | disclosed |
| US-20060017040-A9 | Novel triarylamine polymer, process for producing the same, and use thereof | SUZUKI TAKAO | 2006-01-26 | — | — | US | disclosed |
| EP-1528074-A1 | NOVEL TRIARYLAMINE POLYMER, PROCESS FOR PRODUCING THE SAME, AND USE THEREOF | Tosoh Corporation (JP) | 2005-05-04 | — | — | EP | disclosed |
| US-20040262574-A1 | Novel triarylamine polymer, process for producing the same, and use thereof | TOSOH CORPORATION (JP) | 2004-12-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100176716-A1 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE COMPOUND | KCNK9, TRPA1, KCNK10 | PDK2 235/4885TDP2 3258/4885GABRA1 1405/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.